Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

TRH stimulates human hair growth and extends the hair growth phase.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

p63 is essential for controlling epithelial stem cells and tissue health.

Melatonin may reduce skin damage caused by X-rays in rats.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The skin and thymus develop similarly to protect and support immunity.

Using neurohormones to control keratin can lead to new skin disease treatments.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Latanoprost may cause scalp inflammation and delayed healing.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.